MedPath

Beijing Xuanwu Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations

Phase 2
Recruiting
Conditions
Brain Arteriovenous Malformations
Interventions
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
10
Registration Number
NCT06913725
Locations
🇨🇳

the Department of Neurosurgery, China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China

Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects

Not Applicable
Not yet recruiting
Conditions
Visual Field Defects
Visual Field Loss
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
58
Registration Number
NCT06914505

Carotid Endarterectomy and Stenting Timing

Not Applicable
Not yet recruiting
Conditions
Carotid Endarterectomy
Carotid Stenting
First Posted Date
2025-03-27
Last Posted Date
2025-03-27
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
268
Registration Number
NCT06898151

Rehabilitation Combining Spatiotemporal Spinal Cord Stimulation and Real-time Triggering Exoskeleton After Spinal Cord Injury

Not Applicable
Recruiting
Conditions
Spinal Cord Injury
Neuromodulation
Robot Assisted Gait Training
First Posted Date
2025-03-18
Last Posted Date
2025-03-18
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
10
Registration Number
NCT06881134
Locations
🇨🇳

Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China

The Beijing Longitudinal Disability Survey in Community Elderly

Recruiting
Conditions
Ageing
Disability
Cognitive Impairment
Frailty
Intrinsic Capacity
First Posted Date
2025-03-07
Last Posted Date
2025-03-07
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
1962
Registration Number
NCT06863727
Locations
🇨🇳

Xuanwu Hospital, Capital Medical University, Beijing, China

Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations

Phase 4
Completed
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
Drug: L-Carnitine Injection,1000mg once daily
First Posted Date
2025-02-27
Last Posted Date
2025-04-08
Lead Sponsor
ChaodongWang
Target Recruit Count
4
Registration Number
NCT06849115
Locations
🇨🇳

Xuanwu Hospital, Capital Medical University, Beijing, China

An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease

Early Phase 1
Not yet recruiting
Conditions
Alzheimer Disease
First Posted Date
2025-02-20
Last Posted Date
2025-02-20
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
40
Registration Number
NCT06836180
Locations
🇨🇳

Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Recruiting
Conditions
Epilepsy; Seizure
Blood Pressure
First Posted Date
2025-01-24
Last Posted Date
2025-01-29
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
2000
Registration Number
NCT06790810
Locations
🇨🇳

Liankun Ren, MD, Beijing, Beijing, China

Effect of RNS in Treatment-refractory Tourette's Syndrome

Not Applicable
Recruiting
Conditions
Tourette Syndrome
First Posted Date
2025-01-21
Last Posted Date
2025-01-21
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
10
Registration Number
NCT06785532
Locations
🇨🇳

Xuanwu Hospital, Capital Medical University, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath